Table 2 Subgroup analysis of different intervention periods
group | standard | total | WMD | 95% CI | P | I2 | P (heterogeneity) |
|---|---|---|---|---|---|---|---|
IL-6 |  ≤ 12wks | 5 | 0.615 | -0.763 to 1.993 | 0.382 | 50.1% | 0.091 |
|  |  > 12wks | 4 | -0.761 | -1.369 to-0.153 | 0.014 | 91.3% | 0.000 |
CRP |  ≤ 12wks | 2 | -2.381 | -4.835 to 0.073 | 0.001 | 0.0% | 0.760 |
|  |  > 12wks | 3 | -3.068 | -6.908 to 0.772 | 0.117 | 99.5% | 0.000 |
TNF-α |  ≤ 12wks | 3 | -1.132 | -6.782 to 4.517 | 0.694 | 0.0% | 0.716 |
|  |  > 12wks | 2 | -0.723 | -2.036 to 0.590 | 0.280 | 98.0% | 0.000 |
IL-10 |  ≤ 12wks | 3 | -7.141 | -10.853 to-3.428 | 0.000 | 0.0% | 0.415 |
|  |  > 12wks | 1*# | 0.027 | -0.110 to 0.164 | 0.698 | 60.7% | 0.111 |